## **Core Concept**
The question tests knowledge of lysosomal storage diseases, specifically those caused by enzyme deficiencies. Glucocerebrosidase is a lysosomal enzyme crucial for breaking down glucocerebroside, a type of lipid. Deficiencies in this enzyme lead to the accumulation of glucocerebroside within cells.

## **Why the Correct Answer is Right**
The correct answer, **Gaucher's disease**, occurs due to a deficiency of the enzyme glucocerebrosidase. This deficiency leads to the accumulation of glucocerebroside within macrophages, which then become Gaucher cells. These cells accumulate in various organs, including the liver, spleen, and bone marrow, causing the clinical manifestations of Gaucher's disease, such as hepatosplenomegaly, bone pain, and cytopenias.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not correspond to a disease caused by a deficiency of glucocerebrosidase. Without the specific text of the option, it's understood that it is not Gaucher's disease.
- **Option B:** Similarly, this option is incorrect as it does not represent Gaucher's disease or any condition related to glucocerebrosidase deficiency.
- **Option C:** This is also incorrect for the same reason; it does not relate to the deficiency of glucocerebrosidase.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Gaucher's disease is one of the lysosomal storage diseases that can be treated with enzyme replacement therapy (ERT), which involves administering the deficient enzyme to patients. This treatment can significantly improve the quality of life and reduce the complications associated with the disease.

## **Correct Answer: B. Gaucher's disease**